BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 24487190)

  • 1. Pharmaceutical salts and cocrystals involving amino acids: a brief structural overview of the state-of-art.
    Tilborg A; Norberg B; Wouters J
    Eur J Med Chem; 2014 Mar; 74():411-26. PubMed ID: 24487190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmaceutical cocrystals: an overview.
    Qiao N; Li M; Schlindwein W; Malek N; Davies A; Trappitt G
    Int J Pharm; 2011 Oct; 419(1-2):1-11. PubMed ID: 21827842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmaceutical cocrystals: the coming wave of new drug substances.
    Brittain HG
    J Pharm Sci; 2013 Feb; 102(2):311-7. PubMed ID: 23192888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmaceutical aspects of salt and cocrystal forms of APIs and characterization challenges.
    Cerreia Vioglio P; Chierotti MR; Gobetto R
    Adv Drug Deliv Rev; 2017 Aug; 117():86-110. PubMed ID: 28687273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of pharmaceutical salts and cocrystals to address the issue of poor solubility.
    Elder DP; Holm R; Diego HL
    Int J Pharm; 2013 Aug; 453(1):88-100. PubMed ID: 23182973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmaceutical Cocrystal: An Antique and Multifaceted Approach.
    Panzade PS; Shendarkar GR
    Curr Drug Deliv; 2017; 14(8):1097-1105. PubMed ID: 27758692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmaceutical cocrystals: walking the talk.
    Bolla G; Nangia A
    Chem Commun (Camb); 2016 Jun; 52(54):8342-60. PubMed ID: 27278109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmaceutical Cocrystals as an Opportunity to Modify Drug Properties: From the Idea to Application: A Review.
    Sokal A; Pindelska E
    Curr Pharm Des; 2018; 24(13):1357-1365. PubMed ID: 29278209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancement.
    Löbmann K; Grohganz H; Laitinen R; Strachan C; Rades T
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):873-81. PubMed ID: 23537574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental cocrystal screening and solution based scale-up cocrystallization methods.
    Malamatari M; Ross SA; Douroumis D; Velaga SP
    Adv Drug Deliv Rev; 2017 Aug; 117():162-177. PubMed ID: 28811184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicomponent Pharmaceutical Cocrystals: A Novel Approach for Combination Therapy.
    Srivastava D; Fatima Z; Kaur CD
    Mini Rev Med Chem; 2018; 18(14):1160-1167. PubMed ID: 29512461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization and Quality Control of Pharmaceutical Cocrystals.
    Izutsu KI; Koide T; Takata N; Ikeda Y; Ono M; Inoue M; Fukami T; Yonemochi E
    Chem Pharm Bull (Tokyo); 2016 Oct; 64(10):1421-1430. PubMed ID: 27319284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the counterion on the solubility and physicochemical properties of salts of carboxylic acid drugs.
    David SE; Timmins P; Conway BR
    Drug Dev Ind Pharm; 2012 Jan; 38(1):93-103. PubMed ID: 22118222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salt and cocrystals of sildenafil with dicarboxylic acids: solubility and pharmacokinetic advantage of the glutarate salt.
    Sanphui P; Tothadi S; Ganguly S; Desiraju GR
    Mol Pharm; 2013 Dec; 10(12):4687-97. PubMed ID: 24168322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal Engineering of Pharmaceutical Cocrystals in the Discovery and Development of Improved Drugs.
    Bolla G; Sarma B; Nangia AK
    Chem Rev; 2022 Jul; 122(13):11514-11603. PubMed ID: 35642550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefits of cocrystallisation in pharmaceutical materials science: an update.
    Friščić T; Jones W
    J Pharm Pharmacol; 2010 Nov; 62(11):1547-59. PubMed ID: 21039540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of cocrystals in pharmaceutical science.
    Shan N; Zaworotko MJ
    Drug Discov Today; 2008 May; 13(9-10):440-6. PubMed ID: 18468562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmaceutical cocrystals and poorly soluble drugs.
    Thakuria R; Delori A; Jones W; Lipert MP; Roy L; Rodríguez-Hornedo N
    Int J Pharm; 2013 Aug; 453(1):101-25. PubMed ID: 23207015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of Cocrystallization Approach in Drug Development: Recent Patents Review.
    Shah K; Parmar VK
    Recent Pat Nanotechnol; 2018; 12(2):143-154. PubMed ID: 29473529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cocrystal and its Application in the Field of Active Pharmaceutical Ingredients and Food Ingredients.
    Wang N; Xie C; Lu H; Guo N; Lou Y; Su W; Hao H
    Curr Pharm Des; 2018; 24(21):2339-2348. PubMed ID: 29788878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.